Rutledge Cancer Foundation   Report issue

Foundation Phase 2
Founded: Fort Worth TX United States (2011)
Status: No NME R&D (2011)

Organization Overview

First Clinical Trial
2019
NCT04129151
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Rutledge Cancer Foundation